MannKind Studies Show Afrezza Safe, Effective

MannKind Corp. said that new data indicates its experimental insulin inhaler controls blood sugar levels in diabetics without meaningful, long-term changes in lung function, answering a safety concern of regulators.
Los Angeles Business Journal